U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.86% By Investing.com

<iframe src=”//rcm-na.amazon-adsystem.com/e/cm?o=1&p=22&l=ur1&category=homegarden&banner=02NMTC702K4D0VHE1SR2&f=ifr&linkID=17e0b4ac3a719000706e772761d8ae0e&t=forexz-20&tracking_id=forexz-20″ width=”250″ height=”250″ scrolling=”no” border=”0″ marginwidth=”0″ style=”border:none;” frameborder=”0″></iframe>

© Reuters. U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.86%

Investing.com – U.S. stocks were lower after the close on Wednesday, as losses in the , and sectors led shares lower.

At the close in NYSE, the lost 1.86% to hit a new 1-month low, while the index fell 1.79%, and the index declined 1.56%.

The best performers of the session on the were Johnson & Johnson (NYSE:), which rose 1.55% or 2.01 points to trade at 132.00 at the close. Meanwhile, UnitedHealth Group Incorporated (NYSE:) fell 0.21% or 0.46 points to end at 216.75 and Walt Disney Company (NYSE:) was down 0.32% or 0.41 points to 129.14 in late trade.

The worst performers of the session were Walgreens Boots Alliance Inc (NASDAQ:), which fell 3.42% or 1.87 points to trade at 52.83 at the close. American Express Company (NYSE:) declined 3.29% or 3.84 points to end at 112.86 and Chevron Corp (NYSE:) was down 3.21% or 3.72 points to 112.29.

The top performers on the S&P 500 were Lennar Corporation (NYSE:) which rose 3.77% to 57.82, Paychex Inc (NASDAQ:) which was up 1.78% to settle at 83.35 and Johnson & Johnson (NYSE:) which gained 1.55% to close at 132.00.

The worst performers were Nektar Therapeutics (NASDAQ:) which was down 5.97% to 17.33 in late trade, Capri Holdings Ltd (NYSE:) which lost 5.82% to settle at 29.61 and Macy’s Inc (NYSE:) which was down 5.79% to 14.65 at the close.

The top performers on the NASDAQ Composite were Stars Group Inc (NASDAQ:) which rose 30.05% to 19.91, Resonant Inc (NASDAQ:) which was up 18.32% to settle at 3.230 and Sequential (NASDAQ:) which gained 17.01% to close at 0.26.

The worst performers were Savara Inc (NASDAQ:) which was down 58.47% to 1.030 in late trade, Enlivex Therapeutics Ltd (NASDAQ:) which lost 27.91% to settle at 19.810 and Cancer Genetics Inc (NASDAQ:) which was down 24.97% to 0.114 at the close.

Falling stocks outnumbered advancing ones on the New York Stock Exchange by 2256 to 627 and 81 ended unchanged; on the Nasdaq Stock Exchange, 1916 fell and 721 advanced, while 76 ended unchanged.

Shares in Lennar Corporation (NYSE:) rose to 52-week highs; up 3.77% or 2.10 to 57.82. Shares in Savara Inc (NASDAQ:) fell to 3-years lows; falling 58.47% or 1.450 to 1.030.

The , which measures the implied volatility of S&P 500 options, was up 10.51% to 20.51 a new 1-month high.

Gold Futures for December delivery was up 1.11% or 16.60 to $1505.60 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in November fell 2.13% or 1.14 to hit $52.48 a barrel, while the December Brent oil contract unchanged 0.00% or 0.00 to trade at $57.49 a barrel.

EUR/USD was up 0.03% to 1.0961, while USD/JPY rose 0.01% to 107.19.

The US Dollar Index Futures was down 0.08% at 98.697.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*